Erythropoietin stimulation agents significantly improves outcome in lower risk MDS

H K G Garelius, Alexandra Gwen Smith, Timothy Charles Bagguley, Adele Taylor, Pierre Fenaux, D. Bowen, Argyris Symeonidis, M MIttelmann, R Stauder, Jaroslav Čermák, Guillermo Sanz, Saskia Langemeijer, Luca Malcovati, Ulrich Germing, Raphael Itzykson, Agnès Guerci-Bresler, Dominic Culligan, Ioannis Kotsianidis, Karin A. Koinig, Corine van MarrewijkSimon Crouch, Theo de Witte, E Hellstrom-Lindberg

Research output: Contribution to journalMeeting abstractpeer-review


The EUMDS Registry started in 2008 as a prospective, non-interventional longitudinal study, enrolling newly diagnosed patients with IPSS low or intermediate-1 MDS from 16 European countries and Israel.
Original languageEnglish
Article numberS168
Pages (from-to)69-70
Publication statusPublished - Jun 2022
EventEHA2022 Hybrid Congress - Messe Wien Exhibition & Congress Center, Vienna, Austria
Duration: 9 Jun 202212 Jun 2022

Bibliographical note

© 2022 The Author(s). Published by Wolters Kluwer Health, Inc.

Cite this